TapewireFind a company

person · Reporting owner

Schlosser Mario

Disclosed activity across 3 companies

Tapewire entity
18435
SEC CIK
0001844320

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Duolingo, Inc.DUOL · Entity 3679DirectorOctober 10, 2026October 14, 2026
Khosla Ventures Acquisition Co.KVSA · Entity 141683DirectorMarch 03, 2021March 03, 2021
Oscar Health, Inc.OSCR · Entity 3582DirectorSeptember 03, 2026September 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Duolingo, Inc.

Report date October 10, 2026 · Filed October 14, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect4,378 Reported balance After 2026-10-10 transaction · row 1
1 source row

Row 1 · 2026-10-10 · Grant · Acquired 116 · Balance 4,378

F1: Represents an award of fully vested restricted stock units ("RSUs") in lieu of cash retainers pursuant to reporting person's election under the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Plan"). Each RSU represents the right to receive one share of the Issuer's Class A Common Stock and will be settled either on a date selected by the reporting person pursuant to the Plan or as otherwise provided under the Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of fully vested restricted stock units ("RSUs") in lieu of cash retainers pursuant to reporting person's election under the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Plan"). Each RSU represents the right to receive one share of the Issuer's Class A Common Stock and will be settled either on a date selected by the reporting person pursuant to the Plan or as otherwise provided under the Plan.

Khosla Ventures Acquisition Co.

Report date March 03, 2021 · Filed March 03, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class B Common StockSEC Table II · derivative / convertible securityDirectNot disclosed Reported balance Holding disclosure · report date 2021-03-03 · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · Balance Not disclosed

F1: The Class B Common Stock will automatically convert into shares of Class A Common Stock at the completion of the Issuer's initial business combination, subject to adjustment as set forth in the Amended and Restated Certificate of Incorporation of the Issuer.

Filing footnotes · ownership attribution and instrument terms

F1: The Class B Common Stock will automatically convert into shares of Class A Common Stock at the completion of the Issuer's initial business combination, subject to adjustment as set forth in the Amended and Restated Certificate of Incorporation of the Issuer.

Oscar Health, Inc.

Report date September 03, 2026 · Filed September 08, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect449,444 Reported balance After 2026-09-03 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-09-03 · Sale · Disposed 31,422 · Balance 449,444

F1: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.97 to $31.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.97 to $31.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 06, 2026 Filed Jan 8, 2026 21:17 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass A Common Stock 76,962 Not disclosed Not disclosed
Disclosure

SEC source: 0001844320-26-000004 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 427,142

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025.

F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass B Common Stock · Derivative 86,893 $0.00 $0.00
Disclosure

SEC source: 0001844320-26-000002 · primarydocument.xml · derivative · entry 6

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,532,293

Underlying: Class A Common Stock · 86,893 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025.

F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 96,928 $15.64 $1,515,953.92
Disclosure

SEC source: 0001844320-26-000002 · primarydocument.xml · nonDerivative · entry 4

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 350,180

F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.42 to $15.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass A Common Stock 86,893 Not disclosed Not disclosed
Disclosure

SEC source: 0001844320-26-000002 · primarydocument.xml · nonDerivative · entry 3

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 447,108

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025.

F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass B Common Stock · Derivative 59,800 $0.00 $0.00
Disclosure

SEC source: 0001844320-26-000002 · primarydocument.xml · derivative · entry 5

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,619,186

Underlying: Class A Common Stock · 59,800 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025.

F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 137,933 $15.02 $2,071,753.66
Disclosure

SEC source: 0001844320-26-000002 · primarydocument.xml · nonDerivative · entry 2

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 360,215

F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass A Common Stock 59,800 Not disclosed Not disclosed
Disclosure

SEC source: 0001844320-26-000002 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 498,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025.

F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
December 24, 2025 Filed Dec 30, 2025 21:16 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 38,835 $15.00 $582,525.00
Disclosure

SEC source: 0001844320-25-000012 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 438,348

F1 · shares: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 21:17 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 23,965 $16.59 $397,579.35
Disclosure

SEC source: 0001844320-25-000010 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 477,183

F1 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.37 to $16.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass B Common Stock · Derivative 105,300 $0.00 $0.00
Disclosure

SEC source: 0001844320-25-000007 · primarydocument.xml · derivative · entry 10

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,678,986

Underlying: Class A Common Stock · 105,300 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionClass B Common Stock · Derivative 141,330 $6.36 $898,858.80
Disclosure

SEC source: 0001844320-25-000007 · primarydocument.xml · derivative · entry 9

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,784,286

Underlying: Class A Common Stock · 141,330 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionStock Option (Right to Buy) · Derivative 141,330 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001844320-25-000007 · primarydocument.xml · derivative · entry 8

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 141,330 shares

Expires 2025-12-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option is fully vested and exercisable, and expires on December 7, 2025.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 105,300 $15.05 $1,584,765.00
Disclosure

SEC source: 0001844320-25-000007 · primarydocument.xml · nonDerivative · entry 4

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 501,148

F2 · kind: The sale was effected to cover the cost of exercise and to satisfy the Reporting Person's tax withholding obligation arising from the stock option exercise reported herein.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.83 to $15.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass A Common Stock 105,300 Not disclosed Not disclosed
Disclosure

SEC source: 0001844320-25-000007 · primarydocument.xml · nonDerivative · entry 3

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 606,448

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass B Common Stock · Derivative 286,182 $0.00 $0.00
Disclosure

SEC source: 0001844320-25-000007 · primarydocument.xml · derivative · entry 7

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,642,956

Underlying: Class A Common Stock · 286,182 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionClass B Common Stock · Derivative 413,835 $6.36 $2,631,990.60
Disclosure

SEC source: 0001844320-25-000007 · primarydocument.xml · derivative · entry 6

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,929,138

Underlying: Class A Common Stock · 413,835 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionStock Option (Right to Buy) · Derivative 413,835 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001844320-25-000007 · primarydocument.xml · derivative · entry 5

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,330

Underlying: Class B Common Stock · 413,835 shares

Expires 2025-12-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option is fully vested and exercisable, and expires on December 7, 2025.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 286,182 $15.27 $4,369,999.14
Disclosure

SEC source: 0001844320-25-000007 · primarydocument.xml · nonDerivative · entry 2

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 501,148

F2 · kind: The sale was effected to cover the cost of exercise and to satisfy the Reporting Person's tax withholding obligation arising from the stock option exercise reported herein.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 21:18 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass A Common Stock 286,182 Not disclosed Not disclosed
Disclosure

SEC source: 0001844320-25-000007 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 787,330

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 20:20 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass B Common Stock · Derivative 395,000 $0.00 $0.00
Disclosure

SEC source: 0001844320-25-000005 · primarydocument.xml · derivative · entry 5

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,515,303

Underlying: Class A Common Stock · 395,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 20:20 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionClass B Common Stock · Derivative 555,165 $6.36 $3,530,849.40
Disclosure

SEC source: 0001844320-25-000005 · primarydocument.xml · derivative · entry 4

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,910,303

Underlying: Class A Common Stock · 555,165 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 20:20 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionStock Option (Right to Buy) · Derivative 555,165 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001844320-25-000005 · primarydocument.xml · derivative · entry 3

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 555,165

Underlying: Class B Common Stock · 555,165 shares

Expires 2025-12-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable, and expires on December 7, 2025.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 20:20 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 395,000 $18.43 $7,279,850.00
Disclosure

SEC source: 0001844320-25-000005 · primarydocument.xml · nonDerivative · entry 2

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 501,148

F2 · kind: The sale was effected to cover the cost of exercise and to satisfy the Reporting Person's tax withholding obligation arising from the stock option exercise reported herein.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 20:20 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass A Common Stock 395,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001844320-25-000005 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 896,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 20:16 UTC Oscar Health, Inc. OSCR · Entity 3582 Tax withholdingClass A Common Stock 23,879 $16.66 $397,824.14
Disclosure

SEC source: 0001844320-25-000003 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 501,148

F1 · shares: Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units ("RSUs").

F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units.

Read SEC document
June 11, 2025 Filed Jun 20, 2025 12:01 UTC Duolingo, Inc. DUOL · Entity 3679 GrantClass A Common Stock 379 $0.00 $0.00
Disclosure

SEC source: 0001562088-25-000150 · wk-form4_1750420870.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 379

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Issuer's Class A Common Stock for each RSU upon vesting. 100% of the RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:23 UTC Oscar Health, Inc. OSCR · Entity 3582 Tax withholdingClass A Common Stock 23,879 $13.80 $329,530.20
Disclosure

SEC source: 0001562180-25-004436 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 525,027

F1 · shares: Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units ("RSUs").

F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Also includes 172,940 shares to be issued upon vesting of RSUs that due to clerical error were not included in this total in the Reporting Person's Form 4 filed on March 4, 2025.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 21:51 UTC Oscar Health, Inc. OSCR · Entity 3582 GrantClass A Common Stock 172,269 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-002215 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375,966

F1 · shares: The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2025, subject to the reporting person's continuous service through each vesting date.

F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 21:54 UTC Oscar Health, Inc. OSCR · Entity 3582 Tax withholdingClass A Common Stock 7,970 $14.61 $116,441.70
Disclosure

SEC source: 0001562180-25-001992 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 203,697

F1 · shares: Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units ("RSUs").

F2 · balance_after: Includes 115,294 shares to be issued upon vesting of RSUs previously reported in Table II.

Read SEC document
December 02, 2024 Filed Dec 3, 2024 21:16 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 117 $18.48 $2,162.16
Disclosure

SEC source: 0001562180-24-008103 · primarydocument.xml · nonDerivative · entry 3

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,962

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
December 02, 2024 Filed Dec 3, 2024 21:16 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 6,399 $18.07 $115,629.93
Disclosure

SEC source: 0001562180-24-008103 · primarydocument.xml · nonDerivative · entry 2

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,079

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.46 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:16 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionRestricted Stock Unit · Derivative 14,412 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-008103 · primarydocument.xml · derivative · entry 4

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,705

Underlying: Class A Common Stock · 14,412 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F5 · derivative.exercise_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.

F5 · derivative.expiration_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:16 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionClass A Common Stock 14,412 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-24-008103 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,478

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
September 04, 2024 Filed Sep 5, 2024 00:42 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 1,311 $17.85 $23,401.35
Disclosure

SEC source: 0001562180-24-006662 · primarydocument.xml · nonDerivative · entry 4

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,066

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 to $18.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
September 04, 2024 Filed Sep 5, 2024 00:42 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 1,605 $17.46 $28,023.30
Disclosure

SEC source: 0001562180-24-006662 · primarydocument.xml · nonDerivative · entry 3

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,377

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.63 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 00:42 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 3,198 $17.99 $57,532.02
Disclosure

SEC source: 0001562180-24-006662 · primarydocument.xml · nonDerivative · entry 2

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,982

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.66 to $18.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
September 01, 2024 Filed Sep 5, 2024 00:42 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionRestricted Stock Unit · Derivative 14,412 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-006662 · primarydocument.xml · derivative · entry 5

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,117

Underlying: Class A Common Stock · 14,412 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F6 · derivative.exercise_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.

F6 · derivative.expiration_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.

Read SEC document
September 01, 2024 Filed Sep 5, 2024 00:42 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionClass A Common Stock 14,412 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-24-006662 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,180

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
July 01, 2024 Filed Jul 4, 2024 00:40 UTC Duolingo, Inc. DUOL · Entity 3679 GrantRestricted Stock Units 1,742 $0.00 $0.00
Disclosure

SEC source: 0001562088-24-000189 · wk-form4_1720053593.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,742

F1 · shares: Constitute Restricted Stock Units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Issuer's Class A Common Stock for each RSU upon vesting. 1/3rd of the RSUs shall vest on each anniversary of July 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the RSUs will be fully vested on the third anniversary of the Vesting Commencement Date.

Read SEC document
June 04, 2024 Filed Jun 4, 2024 22:05 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 152 $19.09 $2,901.68
Disclosure

SEC source: 0001562180-24-004664 · primarydocument.xml · nonDerivative · entry 3

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,768

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 22:05 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 5,808 $19.46 $113,023.68
Disclosure

SEC source: 0001562180-24-004664 · primarydocument.xml · nonDerivative · entry 2

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,920

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
June 01, 2024 Filed Jun 4, 2024 22:05 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionRestricted Stock Unit · Derivative 14,411 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004664 · primarydocument.xml · derivative · entry 4

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,529

Underlying: Class A Common Stock · 14,411 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F5 · derivative.exercise_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.

F5 · derivative.expiration_date: The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.

Read SEC document
June 01, 2024 Filed Jun 4, 2024 22:05 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionClass A Common Stock 14,411 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-24-004664 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,728

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
March 10, 2024 Filed Mar 12, 2024 21:17 UTC Oscar Health, Inc. OSCR · Entity 3582 GrantClass A Common Stock · Derivative 172,940 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-002610 · primarydocument.xml · derivative · entry 2

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,940

Underlying: Class A Common Stock · 172,940 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: The Issuer has pulled forward the annual restricted stock unit award that the Reporting Person would otherwise have received for the calendar year 2025 in order to further incentivize and retain the Reporting Person. The restricted stock units will vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2025.

F3 · derivative.expiration_date: The Issuer has pulled forward the annual restricted stock unit award that the Reporting Person would otherwise have received for the calendar year 2025 in order to further incentivize and retain the Reporting Person. The restricted stock units will vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2025.

Read SEC document
March 10, 2024 Filed Mar 12, 2024 21:17 UTC Oscar Health, Inc. OSCR · Entity 3582 GrantClass A Common Stock · Derivative 172,940 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-002610 · primarydocument.xml · derivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,940

Underlying: Class A Common Stock · 172,940 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units will vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.

F2 · derivative.expiration_date: The restricted stock units will vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.

Read SEC document
November 16, 2023 Filed Nov 20, 2023 21:28 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass B Common Stock · Derivative 390,405 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-23-007799 · primarydocument.xml · derivative · entry 5

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,355,138

Underlying: Class A Common Stock · 390,405 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading arrangement dated August 19, 2023, adopted by the Reporting Person.

F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
November 16, 2023 Filed Nov 20, 2023 21:28 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionClass B Common Stock · Derivative 608,430 $1.40 $848,759.85
Disclosure

SEC source: 0001562180-23-007799 · primarydocument.xml · derivative · entry 4

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,745,543

Underlying: Class A Common Stock · 608,430 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading arrangement dated August 19, 2023, adopted by the Reporting Person.

F2 · derivative.exercise_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

F2 · derivative.expiration_date: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document
November 16, 2023 Filed Nov 20, 2023 21:28 UTC Oscar Health, Inc. OSCR · Entity 3582 Exercise / conversionStock Option (Right to Buy) · Derivative 608,430 $0.00 Strike: $1.40 $0.00
Disclosure

SEC source: 0001562180-23-007799 · primarydocument.xml · derivative · entry 3

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 608,430 shares

Expires 2024-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading arrangement dated August 19, 2023, adopted by the Reporting Person.

F5 · derivative.exercise_date: The stock option is fully vested and exercisable, and expires on January 17, 2024.

Read SEC document
November 16, 2023 Filed Nov 20, 2023 21:28 UTC Oscar Health, Inc. OSCR · Entity 3582 SaleClass A Common Stock 390,405 $7.12 $2,779,019.91
Disclosure

SEC source: 0001562180-23-007799 · primarydocument.xml · nonDerivative · entry 2

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,317

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading arrangement dated August 19, 2023, adopted by the Reporting Person.

F3 · kind: The sale was effected to cover the cost of exercise and to satisfy the Reporting Person's tax withholding obligation arising from the stock option exercise reported above.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.99 to $7.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
November 16, 2023 Filed Nov 20, 2023 21:28 UTC Oscar Health, Inc. OSCR · Entity 3582 ConversionClass A Common Stock 390,405 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-23-007799 · primarydocument.xml · nonDerivative · entry 1

Schlosser Mario · CIK 0001844320 · Director · President of Technology & CTO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 447,722

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading arrangement dated August 19, 2023, adopted by the Reporting Person.

F2 · price: The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.